Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study
Titel:
Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study
Auteur:
Locatelli, Franco Mauz-Koerholz, Christine Neville, Kathleen Llort, Anna Beishuizen, Auke Daw, Stephen Pillon, Marta Aladjidi, Nathalie Klingebiel, Thomas Landman-Parker, Judith Medina-Sanson, Aurora August, Keith Sachs, Jessica Hoffman, Kristen Kinley, Judith Song, Sam Song, Gregory Zhang, Stephen Suri, Ajit Gore, Lia